Trian, Solventum

Nelson Peltz’s Trian to Push Solventum to Further Simplify Business
Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare products, was spun out from 3M in Apri
Trian Comments on Solventum’s Sale of its Purification & Filtration Business
Thermo Fisher’s release goes on to suggest that it believes it can more than double the profitability of Purification & Filtration under its corporate umbrella, relative to the business’ current profit as part of Solventum, with much of that improvement driven by lower allocated costs.
Trian Fund Management pushes Solventum for further business separations - WSJ
Investing.com -- Activist investor Trian Fund Management is reportedly planning to urge Solventum to separate additional businesses following the company’s $4.1 billion deal to sell its filtration unit, according to the Wall Street Journal, citing individuals who have knowledge of the situation.
Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports
Feb 26 (Reuters) - Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum (SOLV.N), opens new tab for further business separations following the company's $4.1 billion ...
Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business
Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare products, was spun out from 3M in April 2024.
Trian to push Solventum to shed more businesses, WSJ reports
Nelson Peltz’s Trian Fund Management plans to push Solventum (SOLV) to separate more of its businesses after the company sold its filtration
Trian ‘commends’ Solventum on Filtration unit sale, sees cost cut opportunities
Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...
Solventum forecasts annual profit above estimates on strong surgical product sales
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
Solventum In The Early Stages Of A Multiyear Turnaround Effort
Solventum faces significant challenges in its turnaround, including slow-growing core businesses, share loss, and margin ...
Vontobel Holding Ltd. Grows Holdings in Solventum Co. (NYSE:SOLV)
Vontobel Holding Ltd. grew its holdings in Solventum Co. (NYSE:SOLV – Free Report) by 11.6% during the fourth quarter, ...
Solventum Stock Jumps After $4.1B Deal With Thermo Fisher
Key Takeaways Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to ...
Solventum, facing sagging profit, sells purification business to Thermo Fisher for $4.1 billion
M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to ...